SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.88 |
| Enterprise Value ($M) | -5.83 |
| Book Value ($M) | 4.75 |
| Book Value / Share | 1.48 |
| Price / Book | 0.61 |
| NCAV ($M) | -0.18 |
| NCAV / Share | -0.05 |
| Price / NCAV | -16.27 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.38 |
| Return on Assets (ROA) | -1.37 |
| Return on Equity (ROE) | -3.95 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.72 |
| Current Ratio | 1.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.66 |
| Assets | 15.59 |
| Liabilities | 10.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -24.60 |
| Net Income | -24.13 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -23.79 |
| Cash from Investing | 0.00 |
| Cash from Financing | 15.60 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | CVI Investments, Inc. | 6.20 | ||
| 13G | Intracoastal Capital, Llc | 0.00 | ||
| 13G/A | Hudson Bay Capital Management LP | 4.99 | -91.81 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -52.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 51,703 | 147,462 | 35.06 | |
| 65,835 | 180,767 | 36.42 | |
| 45,429 | 320,936 | 14.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANIX – Anixa Biosciences, Inc. | APM – Aptorum Group Limited |
| APRE – Aprea Therapeutics, Inc. | ARTL – Artelo Biosciences, Inc. |
| ASNS – Actelis Networks, Inc. |